Research ArticleResearch
Preuse/Poststerilization Integrity Testing (PUPSIT): To Do or Not to Do?
Vivek Sheel Gupta, Jitendra Jindal, Ashawant Gupta and Nalini Kant Gupta
PDA Journal of Pharmaceutical Science and Technology May 2020, 74 (3) 301-308; DOI: https://doi.org/10.5731/pdajpst.2018.009449
Vivek Sheel Gupta
Advanced Microdevices Pvt. Ltd. (MDI), Ambala Cantt, India
Jitendra Jindal
Advanced Microdevices Pvt. Ltd. (MDI), Ambala Cantt, India
Ashawant Gupta
Advanced Microdevices Pvt. Ltd. (MDI), Ambala Cantt, India
Nalini Kant Gupta
Advanced Microdevices Pvt. Ltd. (MDI), Ambala Cantt, India

References
- 1.↵CBER/CDER/ORA. Sterile Drug Products Produced by Aseptic Processing: Current Good Manufacturing Practice. US Food and Drug Administration: Rockville, MD, 2004.
- 2.↵Annex 1: Manufacture of sterile medicinal products. Volume 4: EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use. European Commission: Brussels, 2008.
- 3.↵
- Theodore H,
- Meltzer M. W,
- Jornitz
- 4.↵
- Jornitz M.,
- Stering M.
- 5.↵Technical Report No. 26: Sterilizing Filtration of Liquids. Parenteral Drug Association: Bethesda, MD, 2008.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 74, Issue 3
May/June 2020
Preuse/Poststerilization Integrity Testing (PUPSIT): To Do or Not to Do?
Vivek Sheel Gupta, Jitendra Jindal, Ashawant Gupta, Nalini Kant Gupta
PDA Journal of Pharmaceutical Science and Technology May 2020, 74 (3) 301-308; DOI: 10.5731/pdajpst.2018.009449
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.